Status:
RECRUITING
Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs
Lead Sponsor:
Assiut University
Conditions:
Threatened Preterm Labor
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Objective: This trial is designed to compare between the effectiveness of nifedipine plus magnesium sulfate (MgSO4) and MgSO4 alone for tocolysis in women with threatened preterm labor. Patient Popul...
Eligibility Criteria
Inclusion
- Pregnant women with threatened preterm labor defined as 3 or more uterine contractions in 30 minutes confirmed by cardiotocography.
- Gestational age from 28 week + 0 days to (inclusive) 31 weeks + 6 days.
- Women with singleton or multiple pregnancy.
- Women with preterm prelabor rupture of membranes (PROM) will be included if they have uterine contractions.
Exclusion
- Contraindications for the use of either drugs, such as cardiac disease, hypotension, myasthenia gravis, or renal impairment.
- Contraindications for tocolysis, such as intrauterine demise, intrauterine infection, fetal distress, placental separation, or severe pre-eclampsia.
- Cervical dilatation \> 5 cm.
- Cervical length \> 30 mm by trans-vaginal ultrasound.
- Cervical cerclage.
Key Trial Info
Start Date :
April 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT05345132
Start Date
April 10 2022
End Date
February 1 2026
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71111